The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 122.00
Bid: 120.00
Ask: 124.00
Change: 5.50 (4.72%)
Spread: 4.00 (3.333%)
Open: 116.50
High: 122.00
Low: 116.50
Prev. Close: 116.50
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

28 Mar 2013 12:20

RNS Number : 1478B
Transense Technologies PLC
28 March 2013
 



28 March 2013

Transense Technologies plc

Interim Results

Transense Technologies plc (AIM:TRT) ("Transense" or the "Company") is pleased to announce its interim results for the 6 months ended 31 December 2012.

Highlights

·; Sales reached a record level: £967,000 (2011: £414,000)

·; Receipt of the first major order from Anglo American for the iTrack system

·; First full factory fit out with IntelliSAW sensors, at soon to be completed, state-of-the-art, Fuxin Special Steel Company (FSSC) Steel Plant in China

·; Continued progress towards commercialisation of the torque flexplate in partnership with General Motors

 

Post Period Highlights and Outlook

·; iTrack field trials currently underway in South America, Australia and Indonesia

·; Record quarterly IntelliSAW orders since the start of 2013, including:

o ETT (IntelliSAW Taiwan distributor)

o Al Mashariq (IntelliSAW Saudi distributor), marking the first major contract win in that region

o 33 system installation in South Korea for POSCO, the country's largest steel manufacturer, with the potential for further larger deployments

·; Growing pipeline, pilots and number of distributors for both divisions across multiple geographies provide encouraging signs for future performance

·; Announcement today of conditional placing to raise approximately £290,000 (net of expenses)

 

Graham Storey, CEO, commented: "The Board is encouraged that, against the backdrop of continuing progress on Transense's long-term development projects with the likes of GM, Translogik and IntelliSAW are now beginning to provide the near- and medium-term revenue to support the Company until such time as royalty revenues arrive.

"The first six months of our financial year have seen record sales for the Transense Group and we are more optimistic than ever that we have the right products, for the right markets at the right time to give the Company the best possible opportunity for its future commercial success."

For more information, please contact:

 

Transense Technologies plc

Tel: +44 1869 238 380

Graham Storey, Chief Executive

N+1 Singer - Nominated Adviser & Broker Shaun Dobson, Aubrey Powell

Tel: +44 20 7496 3000

Newgate Threadneedle

Tel: +44 20 7653 9850

Caroline Evans-Jones, Robyn McConnachie

 

About Transense Technologies

 

Based in Oxfordshire, UK, Transense has developed patent-protected sensor systems for use in diverse high growth markets. Developed in conjunction with partners including McLaren Electronic Systems and General Motors, Transense's Surface Acoustic Wave (SAW), wireless, battery-less, sensor systems offer significant advantages over legacy wireless sensor systems. Via two wholly owned divisions, IntelliSAW and Translogik, Transense is targeting the high growth global electrical Smart Grid applications market and the transport industry respectively.

 

Transense's sensors are also being used in the wind turbine monitoring industry. The Company is part of a consortium of nine companies ("IntelWind") that has begun development on a major EU funded project to improve the efficiency and reliability of wind turbines.

 

Transense's shares are admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: "TRT").

www.transense.co.uk

 

Chairman's Statement

Sales in the six months to 31 December 2012 reached a record level for Transense of £967,000 (2011: £414,000). The post-tax loss for the period of £1,019,000 (2011: £1,036,000) reflects, as earlier indicated, the continuing cost of funding our US operations, which commenced in September 2011 and are expanding as the potential for new business increases.

The highlight of the first half of our financial year was the receipt of the first major order, after lengthy field trials, from Anglo American for our iTrack system, which enables mine operators to track vehicles in real-time and receive early warning of possible tyre malfunctions or hazards. This live data enables prompt action to be taken, thereby reducing the risk of injury to personnel and damage to property, and improving safety standards. Additionally, the ability of iTrack to monitor tyre temperature and pressure can extend tyre life and reduce truck downtime to mine operators, thereby increasing productivity. We are anticipating further orders from South Africa and are continuing to run field trials in Australia and South America. iTrack is marketed by our Translogik division, which, further assisted by the growth in sales of its tyre inspection Probe kits, nearly doubled its sales in the six month period to December to £223k (2011: £128k).

Intellisaw, in the USA, also saw a significant increase in sales, which amounted to £235,000 in the six-month period (2011: £42,400) despite the lengthy trial periods during which potential customers test our wireless sensor systems for smart grid applications. We have great confidence that further breakthroughs will be achieved. Our sales team has travelled extensively throughout the Far East and South America, and also in India and Saudi Arabia. Our sensors have a special relevance in developing countries experiencing rapid industrialisation, and the positive feedback we are receiving, alongside the growing number of distributors and trials means we believe it is only a matter of time before a consistent and accelerating level of sales materialises. In the meantime we experience meaningful regular cash outflows to meet overhead and working capital needs.

Transense continues to maintain progress in our relationship with General Motors for, in particular, the flexplate application, and where a second leading North American OEM has placed an order for the development of a prototype for vehicle evaluation. The joint venture with McLaren is proceeding well and further orders have recently been received.

Trading in the second half of the year and capital base

Overall, whilst formal order intake since January has been at a similar level as last year, the number of enquiries received and quotations submitted has been considerably higher. Indeed, quarter on quarter the momentum grows, constrained only by our working capital needs. It has taken time to produce and market our sensors, but it is clear that the choices we made three years ago have been validated by the market. In short, it has been such an encouraging six months, and, although neither the timing nor size of any new orders can be certain, the Board reasonably expects near term progress with further announcements likely to be made. It is possible (although by no means certain) that one or more orders may materialise within a short period; further announcements will be made as required.

As a significant proportion of our projected sales comprise a small number of high value orders and the timing of the receipt of these orders is outside of our control, the ability to predict accurately the timing of delivery of any such orders remains challenging. Accordingly the level of reported sales may be materially affected in any given reporting period. Furthermore, the uncertainties around the timing of expected orders make cash flow projections more uncertain than usual.

The Board has therefore decided that it is in the best interests of the Company to raise a relatively small sum as quickly and with as little expense as possible. A modest placing is therefore being conducted within existing authorities to issue new shares and is described in a separate announcement issued today.

We remain greatly encouraged by the underlying trends in interest and demand for our products and, assuming the anticipated orders materialise, it may become appropriate to raise further funds to fuel that success. In such a case, we would intend to make an appropriate offer to our existing shareholders to participate as part of any such fundraising.

 

David Kleeman

ChairmanCEO Report

Over the last few years, the Company has executed on its revised commercial strategy of repositioning Transense away from being purely a technology transfer company, to one that has a broad and diverse range of products leveraging its patented surface acoustic wave ('SAW') technology and sensor expertise. Having successfully established its two trading divisions, IntelliSAW and Translogik, developed class-leading products for its target markets, and built a large and rapidly expanding global partner and distribution network, it is the Board's view that the record revenue growth seen in the last six months may well represent the start of a new chapter of commercial success for the Company.

Transense

The Company continues to leverage its patented SAW (Surface Acoustic Wave) technology with existing and new projects, both in the automotive and non-automotive fields.

Progress continues towards commercialisation of the torque flexplate in partnership with General Motors ('GM'), with further applications of the technology being evaluated. Transense is providing ongoing engineering support to the GM development team. The flexplate is an integral part of the vehicle powertrain control system and has the potential to improve vehicle driveability, reduce fuel consumption and improve transmission shift quality.

In Motorsport, Transense is now supplying drive shafts to McLaren for use in Indycar, receiving income from sales and profit share as part of the Joint Development Agreement, as well as receiving royalties from its licensee, Stack, in regards to its tyre pressure monitoring system (TPMS).

The Intelwind project, to improve the efficiency and reliability of wind turbines, funded by the EU's Seventh Framework Programme (FP7) is continuing and Transense is now in discussions with regards to further FP7 initiatives.

As part of the Company's strategy to diversify into non-automotive markets, a number of new paid for customer-driven projects are progressing, applying Transense's technology for use in avionics, space, marine and a variety of industrial applications.

Translogik

Translogik's iTrack order from Anglo American subsidiary, Kumba Iron Ore, in August 2012 was the first commercial success for Translogik's iTrack system in South Africa. Deployment of those systems is ongoing and the Company are hopeful that further orders will follow, as the benefits of the system become apparent through analysis of the live data the iTrack system is able to provide to vehicle operators, both in terms of improved safety and reduced vehicle downtime.

New routes to market for the iTrack system with companies providing complementary products to the mining and earthmoving truck markets have been established and the iTrack system's capabilities continue to grow. Further field trials are currently underway in South America, Australia and Indonesia.

Dramatic recent increases in the costs of fuel and rubber have led to a surge of interest in Translogik's tread depth and pressure measurement products. Since the start of our financial year, Translogik has delivered probes to fourteen OEMs (Original Equipment Manufacturers), sixteen Value Added Resellers/System Integrators and four software R&D departments in twenty different countries, and it would be reasonable to expect further large OEM orders for the range of tyre inspection probes in the remainder of the year.

Translogik continues to develop a variety of tyre inspection systems with partners across the globe on a variety of Apple and Android based platforms. A notable recent project with Brisa Bridgestone in Turkey (www.brisa.com.tr/English/Default.aspx) has led to a flow of ongoing orders for inspection probes.

IntelliSAW

IntelliSAW is continuing to make significant commercial progress, securing record quarterly orders since the start of 2013. Notable recent orders include those from ETT (IntelliSAW Taiwan distributor), Al Mashariq (IntelliSAW Saudi distributor), marking the first major contract win in that region and a 33 system installation in South Korea for POSCO, the country's largest steel manufacturer, with the potential for further larger deployments.

Additionally, five new pilots have begun or will begin imminently. The pilots will be spread across the United States, China, Abu Dhabi and South Korea. These take the total number of pilots to fifteen, including those already underway at JSW Steel, Petrobras, Southern China Grid, Gujarat State Electricity Corp, State Grid Corp of China, Formosa Plastics Group, Nan Ya Switchgear, Progress/Duke Energy and the Orlando Utility Commission.

Seven new distributors have been appointed in the Benelux region, Poland, Israel, Egypt, Indonesia, Chile and the Philippines, expanding the Company's global distribution network to seventeen partners.

A recent highlight is the deployment of IntelliSAW's thermal monitoring systems for critical asset monitoring of 340 switchgears at the soon to be completed, state-of-the-art, Fuxin Special Steel Company (FSSC) Steel Plant in the Zhangzhou Longchi Development Zone of Fujian Province, near Xiamen, China.

At the plant, the IS485 thermal monitoring systems have been integrated into 340 medium voltage switchgear manufactured by Nan Ya Switchgear in cooperation with IntelliSAW's integration partner, ETT. Factory-installed by Nan Ya Switchgear, a division of Formosa Plastics Group (FPG), the IS485 systems will help ensure a reliable and safe supply of electric power throughout the factory by continuously monitoring 2000+ critical points inside the switchgears, thus helping to protect a $2.2 billion investment by FSSC in constructing the factory. This is the first fit-out of an entire factory and the Company believes the prospects for further orders via ETT to be extremely positive.

As part of the Company's coordinated global marketing initiative, IntelliSAW's IS485 wireless/passive thermal monitoring system will be on show at the Hannover Messe (http://www.hannovermesse.de/home) in conjunction with our regional partners from the 8th to 12th April 2013, as well as the WEPower exhibition in Saudi from May 12th-14th 2013 (http://www.wepower-sa.com)

Outlook

The Board is encouraged that, against the backdrop of continuing progress on Transense's long-term development projects with the likes of GM, Translogik and IntelliSAW are now beginning to provide the near- and medium-term revenue to support the Company until such time as royalty revenues arrive.

The recent fit-out of an entire factory with IntelliSAW IS485 systems for Fuxin Steel in China demonstrates the scale of deployments that the Company is targeting, and we expect these deployments to accelerate during the coming year. With Translogik, the Board believes that Kumba Iron Ore's decision to choose its iTrack system over competing products after lengthy field trials is indicative of the system's value. The Board further believes that the market opportunity is significant, not only with potential further orders from Kumba, but also with other trials currently underway. However, as we have found over the last year or so, customer testing, validation and integration of these systems can be complex and time-consuming, so it is difficult to gauge the timing of orders with any certainty. Notwithstanding this, the high levels of interest and demand for our products give us increasing confidence that, as the business develops over time, the flow of orders will become more regular.

In summary, the first six months of our financial year have seen record sales for the Transense Group and we are more optimistic than ever that we have the right products, for the right markets at the right time to give the Company the best possible opportunity for its future commercial success.

 

Graham Storey

CEO

 

Transense Technologies plc

Condensed Consolidated Statement of Comprehensive Income

Six months to 31 Dec 12

Six Months to 31 Dec 11

18 Months to 30 Jun 12

(Unaudited)

(Unaudited)

(Audited)

£'000

£'000

£'000

Continuing operations

Revenue

967

414

1,014

Cost of sales

(286)

(219)

(449)

Gross profit

681

195

565

Administrative expenses

(1,731)

(1,266)

(3,997)

Operating loss

(1,050)

(1,071)

(3,432)

Financial income

2

7

34

Loss before taxation

(1,048)

(1,064)

(3,398)

Taxation

29

28

73

Total comprehensive income for the period

(1,019)

(1,036)

(3,325)

Basic and fully diluted loss per share

(0.45)

(0.78)

(2.24)

 

 

 

Transense Technologies plc

Condensed Consolidated Statement of Financial Position

Six months to 31 Dec 12

Six months to 31 Dec 11

18 Months to 30 Jun 12

(Unaudited)

(Unaudited)

(Audited)

£'000

£'000

£'000

Non current assets

Property, plant and equipment

172

182

149

Intangible assets

1,113

1,230

1,188

1,285

1,412

1,337

Current assets

Inventory

156

130

140

Corporation tax receivable

103

56

73

Trade and other receivables

493

527

299

Cash and cash equivalents

813

1,495

195

1,565

2,208

707

Total assets

2,850

3,620

2,044

Current liabilities

Trade and other payables

(263)

(357)

(254)

Current tax liabilities

(33)

(27)

(33)

Total liabilities

296

(384)

(287)

Net assets

2,554

3,236

1,757

Capital and reserves

Share capital

8,802

8,589

8,591

Share premium

11,301

9,768

9,753

Warrant reserve

430

430

430

Accumulated deficit

(17,979)

(15,551)

(17,017)

Shareholders' funds

2,554

3,236

1,757

 

 

 

 

 

Transense Technologies plc

Condensed Consolidated Statement of Changes in Equity (Unaudited)

Issued share capital

Share premium account

Warrant Reserve

Accumulated deficit

Total equity

£'000

£'000

£'000

£'000

£'000

Balance at 1 January 2011

8,145

8,956

710

(14,047)

3,764

Loss for the period

-

-

-

(3,325)

(3,325)

Shares issued and share premium

446

797

-

-

1,243

Transfer between reserves

(280)

(280)

-

Share based transactions

-

-

-

75

75

Balance at 30 June 2012

8,591

9,753

430

(17,017)

1,757

Loss for the period

-

-

-

(1,019)

(1,019)

Shares issued and share premium

211

1,548

-

-

1,759

Share based transactions

-

-

-

57

57

Balance at 31 December 2012

8,802

11,301

430

(17,979)

2,554

 

 

 

 

 

 

 

Transense Technologies plc

Condensed Consolidated Statement of Cash Flows

Six Months to 31 Dec 12

Six Months to 31 Dec 11

18 Months to 30 Jun 12

(Unaudited)

(Unaudited)

(Audited)

£'000

£'000

£'000

Cash flow from operating activities

Loss for the period

(1,048)

(1,064)

(3,398)

Adjustments for

Financial income

(2)

(7)

(34)

Depreciation of property, plant and equipment

32

23

78

Amortisation and impairment of intangible assets

109

120

320

Loss on disposal of fixed assets

-

-

11

Equity settled share based payment

57

9

75

Operating cash flows before movements in working capital

(852)

(919)

(2,948)

Change in receivables

(222)

(110)

101

Change in payables

9

(10)

(113)

Change in Inventories

(15)

(14)

(99)

Cash used in operations

(1,080)

(1,053)

(3,059)

Taxation recovered

29

17

65

Net cash used in operations

(1,052)

(1,036)

(2,994)

Cash flows from investing activities

Interest received

2

7

34

Acquisition of property, plant & equipment

(55)

(58)

(112)

Acquisition of intangible assets

(33)

(42)

(114)

Proceeds from sale of fixed assets

-

-

72

Net cash used in investing activities

(86)

(93)

(120)

Cash flows from financing activities

Proceeds from issue of equity share capital

1,756

1,269

1,243

Share premium refund of issuance fees

Net cash used for financing activities

1,756

1,269

1,243

Net (decrease)/increase in cash and cash equivalents

618

140

(1,871)

Cash and cash equivalents at beginning of period

195

1,355

2,066

Cash and cash equivalents at end of period

813

1,495

195

 

 

 

 

Notes to the Interim results for the six months to 31 December 2012

1 Accounting Policies

The accounting policies and presentation applied by the Group in these condensed consolidated interim financial statements are the same as those applied by the Group in its consolidated financial statements as at and for the year ended 30 June 2012, except as noted below.

2 Reporting Entity

Transense Technologies plc. ("the Company") is a company incorporated in the United Kingdom under the Companies Act 2006. These condensed consolidated interim financial statements of the Company as at and for the six months ended 30 June 2011 comprises the Company and its subsidiary (together referred to as "the Group" and individually as "Group entities"). These condensed consolidated interim financial statements are presented in pounds sterling, rounded to the nearest thousand.

The consolidated financial statements of the Group as at and for the period ended 30 June 2012 are available upon request from the Company's registered office or at www.transense.co.uk

These condensed consolidated interim financial statements are unaudited.

3 Going Concern

The financial statements have been prepared on a going concern basis, which the Directors believe to be appropriate for the reason below.

At 31 December 2012, the Group had net assets of £2.5m and a positive cash balance of £813,000. The Group meets its day to day working capital requirements through existing cash reserves. The Directors have prepared internal cash flow forecasts for the period to 30 June 2014. These forecasts make a number of operational assumptions, the most significant of which are as follows:

1. the raising during April of at least £290,000 net of costs through a placing of new equity shares in respect of which the Group's broker has received a placing letter for the full amount.

2. an increased level of sales reflecting recently announced orders and pilots plus future anticipated orders.

The Directors believe that the proceeds from the planned placing will be in line with their expectations. The completion is subject only to legal and administrative procedures, notably the admission of the shares to AIM and settlement and therefore the Directors are confident that this will be completed prior to the Group requiring additional funds.

As far as the increased level of sales are concerned, were the timing of those sales to be delayed, then the group may require further additional funding. The Company are currently in discussions with bankers to provide further facilities to fund the continuing expansion of the business which would provide sufficient funding in anticipation of the operations becoming cash generative.

The Directors have considered controllable mitigating actions available to them to extend the period during which it can operate with the remaining cash reserves. However, the ability to do this may be limited. On the basis that the expected proceeds from the forecast increased level of sales materialises (or that appropriate bank facilities are made available), the Directors consider that the Group will continue to meet its liabilities as they fall due for the foreseeable future. However, there can be no certainty in relation to all these matters.

The Directors have concluded that the achievement and timing of the anticipated orders and also the potential requirement, and ability, to obtain external financing both represent material uncertainties that may cast significant doubt upon the Group's ability to continue as a going concern. The Group may, therefore, be unable to continue realising their assets and discharging their liabilities in the normal course of business. The financial statements do not include any adjustments that would result from the basis of preparation being inappropriate.

4 Corporation tax and Deferred tax

The Company is entitled to a Corporation Tax credit in respect of expenditure on Research and Development. No deferred tax asset is recognised in these financial statements in respect of trading losses to date.

5 Consolidated Accounts

These accounts include the trading of IntelliSAW inc. for the six months to 31 December 2012.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR SEMFEAFDSEFD
Date   Source Headline
1st May 20247:00 amRNSDirector/PDMR - Acquisition of Shares
30th Apr 20245:00 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSTRT joins £37.8m LANDOne project with Airbus & ATI
17th Apr 20246:00 pmRNSTransaction in Own Shares & TVR
15th Apr 20242:51 pmRNSTransaction in Own Shares & TVR
28th Mar 20245:00 pmRNSTotal Voting Rights
25th Mar 20243:35 pmRNSTransaction in Own Shares & TVR
20th Mar 20249:10 amRNSRyan Maughan appointed as Managing Director
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 20242:40 pmRNSHolding(s) in Company
19th Feb 20247:00 amRNSInterim Results & Investor Presentation
15th Feb 20247:00 amRNSHolding(s) in Company
2nd Feb 20245:41 pmRNSTransaction in Own Shares & TVR
31st Jan 20245:00 pmRNSTotal Voting Rights
12th Jan 20247:00 amRNSDirector/PDMR Shareholding
11th Jan 20249:52 amRNSTransaction in Own Shares & TVR
8th Jan 20247:00 amRNSTranslogik Update – Appointment of Sales Director
1st Dec 20237:00 amRNSGrant of share options to Director and employee
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 202311:11 amRNSDirector/PDMR Shareholding
29th Nov 20233:01 pmRNSDirector/PDMR Shareholding
29th Nov 202310:45 amRNSResult of AGM
29th Nov 20237:00 amRNSAGM Statement & Trading Update
24th Nov 20231:11 pmRNSHolding(s) in Company
9th Nov 202312:12 pmRNSDirector/PDMR Shareholding
6th Nov 20234:48 pmRNSTransaction in Own Shares & TVR
25th Oct 202310:00 amRNSPosting of Annual Report & Notice of AGM
16th Oct 20233:23 pmRNSHolding(s) in Company
3rd Oct 20236:00 pmRNSHolding(s) in Company
28th Sep 20235:22 pmRNSHolding(s) in Company
27th Sep 20233:18 pmRNSHolding(s) in Company
26th Sep 20233:37 pmRNSDirector/PDMR Shareholding
25th Sep 202311:00 amRNSDirector/PDMR Shareholding
25th Sep 20237:00 amRNSFinal Results & Investor Presentation
22nd Sep 20239:25 amRNSHolding(s) in Company
31st Aug 20235:00 pmRNSTotal Voting Rights
29th Aug 20238:30 amRNSTransaction in Own Shares & TVR
23rd Aug 20237:00 amRNSNotice of Results & Investor Presentation
16th Aug 202310:03 amRNSHolding(s) in Company
11th Jul 20237:00 amRNSYear End Trading Update
30th Jun 20235:00 pmRNSTotal Voting Rights
22nd Jun 20234:24 pmRNSTransaction in own shares & TVR
19th Jun 20234:29 pmRNSHolding(s) in Company
16th Jun 20235:57 pmRNSTransaction in own shares & TVR
5th Jun 20237:00 amRNSSAW: Extension of scope of licence agreement
2nd Jun 20232:36 pmRNSTransaction in own shares & TVR
31st May 20235:00 pmRNSTotal Voting Rights
3rd May 20237:00 amRNSNew Automotive eDrive Business Contract
2nd May 202312:48 pmRNSAppointment of Non-Executive Director
2nd May 202310:23 amRNSTransaction in own shares & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.